Henning Dralle
About
In The Last Decade
Henning Dralle
566 papers receiving 26.1k citations
Hit Papers
Peers
Comparison fields: 5 of 164
- Endocrinology, Diabetes and Metabolism 15.9k
- Surgery 13.8k
- Epidemiology 6.1k
- Oncology 4.7k
- Molecular Biology 4.0k
Countries citing papers authored by Henning Dralle
This map shows the geographic impact of Henning Dralle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henning Dralle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henning Dralle more than expected).
Fields of papers citing papers by Henning Dralle
This network shows the impact of papers produced by Henning Dralle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henning Dralle. The network helps show where Henning Dralle may publish in the future.
Co-authorship network of co-authors of Henning Dralle
This figure shows the co-authorship network connecting the top 25 collaborators of Henning Dralle. A scholar is included among the top collaborators of Henning Dralle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henning Dralle. Henning Dralle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 6 | |
| 4 | 5 | |
| 5 | 6 | |
| 6 | 18 | |
| 7 | 3 | |
| 8 | 7 | |
| 9 | 5 | |
| 10 | 2 | |
| 11 | 10 | |
| 12 | 4 | |
| 13 | 3 | |
| 14 | 18 | |
| 15 | Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension breakdown → | 211 |
| 16 | 37 | |
| 17 | 31 | |
| 18 | Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial breakdown → | 1082 |
| 19 | 19 | |
| 20 | 16 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.